Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer [Phase 2, Phase 3]

View source ↗

Summary

Pfizer is enrolling patients in a Phase 2/Phase 3 study testing PF-08634404 with chemotherapy for untreated advanced or metastatic gastric cancer, gastroesophag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• PF-08634404

Snippet

Sponsor: Pfizer | Conditions: Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma, Metastatic Gastric Cancer | Phase 2, Phase 3 | Status: RECRUITING